BioTech Social Media and Updates

Therapeutic SASP Targets Halt Brain Cell Senescence Spread
SocialApr 3, 2026

Therapeutic SASP Targets Halt Brain Cell Senescence Spread

Characterizing the SASP-Dependent Paracrine Spreading of Senescence Between Human Brain Cell Types "we identified specific SASP targets for therapeutic intervention in the context of human brain cells and thereby informed the SASP-dependent reaction of immune cells and age-related tissue dysfunction across...

By David Barzilai, MD PhD
Time-to-Market Is SynBio’s Biggest Scaling Hurdle
SocialApr 3, 2026

Time-to-Market Is SynBio’s Biggest Scaling Hurdle

Great conversation with Jamie Bacher about the one challenge synbio must solve: time to market. Jamie argues that scaling biotech requires more than great strains—process dev, downstream, analytics, and new financing models all matter. Excited to have him at #SynBioBeta2026. Read the...

By John Cumbers
CZI Biohub Leverages AI to Outpace Funders in Biomedical Research
SocialApr 3, 2026

CZI Biohub Leverages AI to Outpace Funders in Biomedical Research

CZI’s Biohub aims to harness AI for groundbreaking biomedical research, potentially surpassing other leading funders in influence and investment. Wendy Paris Reports: https://tinyurl.com/28f6rnzc Related IP Resources: The Chan Zuckerberg Initiative -https://tinyurl.com/nhhw9a9u Disease Research Grants -https://tinyurl.com/akr4pv9h Grants for Science Research -https://tinyurl.com/mpdstvy2 Tech Philanthropists -https://tinyurl.com/bdewp5v8 Journalism

By Inside Philanthropy
Cutting Illumina DNA Prep Volume Without Introducing Bias
SocialApr 3, 2026

Cutting Illumina DNA Prep Volume Without Introducing Bias

Colleague is looking for input on reducing library prep costs for metagenomic sequencing using Illumina DNA Prep kit. They ask "Has anyone successfully reduced library prep volumes without introducing bias? If so, how much reduction worked for you?"

By Jonathan Eisen
NR & NMN Boost Blood NAD+ via Gut Microbiome
SocialApr 3, 2026

NR & NMN Boost Blood NAD+ via Gut Microbiome

The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans “Collectively, the clinical data combined with the ex vivo human microbiota and human whole-blood experiments led us to propose a human model where NR and...

By David Barzilai, MD PhD
Oral NR/NMN Boosts Blood and Brain NAD in Two Weeks
SocialApr 3, 2026

Oral NR/NMN Boosts Blood and Brain NAD in Two Weeks

The NAD-brain pharmacokinetic study of NAD augmentation in blood and brain using oral precursor supplementation 🔎 “… oral NR or NMN in humans produces a slow but robust and sustained elevation of systemic and cerebral NAD that stabilizes after ∼2 weeks…” https://t.co/Hvp1NvRwl0

By David Barzilai, MD PhD
Epigenetic Aging Clocks Lack Reliable Real‑world Accuracy
SocialApr 3, 2026

Epigenetic Aging Clocks Lack Reliable Real‑world Accuracy

This is a thoughtful essay on a new preprint from Raghav Sehgal and Albert Higgins-Chen that’s worth your time. It highlights something we don’t talk about enough: for biological aging clocks to be useful outside of research, they need to...

By Matt Kaeberlein, PhD
Trump Targets NIH Funding Amid $1.5T War Spend
SocialApr 3, 2026

Trump Targets NIH Funding Amid $1.5T War Spend

Trump once again going for draconian cuts to NIH, though not as catastrophic as he sought for the last round (and didn't get). Meanwhile, he wants $1.5T for war. I doubt he'll be any more successful with NIH cuts than...

By John Carroll
Dead Worms Boost Lifespan Through Separate Mechanisms
SocialApr 3, 2026

Dead Worms Boost Lifespan Through Separate Mechanisms

Exposure to deceased remains of conspecifics extends the lifespan of young and aged C. elegans via distinct pathways https://t.co/B1VE91Y1lj

By David Barzilai, MD PhD
Aging May Be Evolutionary Program, Not Random Decay
SocialApr 3, 2026

Aging May Be Evolutionary Program, Not Random Decay

Is aging programmable? It implies there IS a program created by evolution, not only accident or entropy. But that's a debate. Here's a paper by business consultant Michael Ringel, on this very topic, with many good citations. https://t.co/fREM4AHnJG

By Antonio Regalado
GEN's First Top‑10 Organoid Companies and Growth Drivers
SocialApr 3, 2026

GEN's First Top‑10 Organoid Companies and Growth Drivers

3April: Which are GEN's first-ever Top 10 Organoid Companies (5 publicly traded, 5 privately held)? And what's driving growth for these and other organoid companies? Check out my latest A-List for @GENbio: https://t.co/6D589lVk9s

By Alex Philippidis
Synonymous Mutations Can Disrupt TF Sites and Cause Disease
SocialApr 3, 2026

Synonymous Mutations Can Disrupt TF Sites and Cause Disease

Every exome analysis I have seen filters out synonymous variants first. "Silent mutations, skip them." But 15% of human codons sit inside transcription factor binding sites. A synonymous change that breaks a TF site can cause disease with the protein completely intact. https://t.co/yzkdi82kEd

By Ming Tang
Debating Brainless Clones as Personal
SocialApr 3, 2026

Debating Brainless Clones as Personal

Are you pro-bodyoid or anti-bodyoid? For the purpose of this poll, a bodyoid is: a newborn clone of you lacking a cortex, a.k.a. a brainless clone, gestated by a paid surrogate. It's organs are a perfect match (isogenic) to you...

By Antonio Regalado
Black‑Box Warnings Can Slash Drug Revenues—Investors Beware
SocialApr 3, 2026

Black‑Box Warnings Can Slash Drug Revenues—Investors Beware

Approved drugs can have a "black box" (aka boxed) warning, the highest safety-related warning that FDA can put on an approved drug Usually applied to multiple drugs in the same class it can hamper revenue potential if alternatives exist Investors should be...

By Biotech Investor
Annotate Second Methionine when CDS Begins with MM
SocialApr 3, 2026

Annotate Second Methionine when CDS Begins with MM

Question: If a transcript has a CDS that starts with two methionines, what's the general rule for sequence annotation? Should I make it so if two METs in a row at the beginning, annotate the closest MET to rest of sequence...

By Sebastian Cocioba
Japan Approves Conditional Stem‑cell Parkinson’s Replacement Therapy
SocialApr 3, 2026

Japan Approves Conditional Stem‑cell Parkinson’s Replacement Therapy

Woah. I'm slightly embarrassed that I missed this for a few weeks. Finally there is approval, in a Large Nation, for a stem cell-based REPLACEMENT therapy for an age-related condition. The condition is, no surprise, Parkinson's, which I always highlight...

By Aubrey de Grey
Personalized NAD Boosting Needed; Redox Fingerprints Reveal Disease
SocialApr 3, 2026

Personalized NAD Boosting Needed; Redox Fingerprints Reveal Disease

Dynamics of blood NAD and glutathione in health, disease, aging and under NAD-booster treatment “In healthy population (n=299;18-70 year-olds) redox metabolites follow normal distribution in blood and remain unchanged during aging. NAD-boosting increased 4-6 fold the blood NAD+ depending on individual,...

By David Barzilai, MD PhD
Mono Infection Triples Risk of Developing Multiple Sclerosis
SocialApr 3, 2026

Mono Infection Triples Risk of Developing Multiple Sclerosis

New study has strengthened link between infectious mono and Multiple Sclerosis. By analyzing 2 decades of health records, researchers found people who contracted mono as teenagers or adults were 3x more likely to develop MS later vs those who didn’t https://t.co/6DLZMEWyU6

By Scott Gottlieb
Cell‑Free DNA Production Ends Decades‑Old Cloning Bottleneck
SocialApr 3, 2026

Cell‑Free DNA Production Ends Decades‑Old Cloning Bottleneck

Most of synthetic biology has been completely transformed in the last decade. DNA manufacturing? Still running on cloning workflows from the 1970s. That's the bottleneck Jodi Barrientos, CEO of @ribbonbiolabs, is tackling head-on — and she's on the @SynBioBeta Main Stage on...

By John Cumbers
H5N1 Bird‑to‑Cattle Spillover Traced Across US
SocialApr 3, 2026

H5N1 Bird‑to‑Cattle Spillover Traced Across US

So pleased to contribute to this preprint on H5N1 spillover from birds to dairy cattle from the Moo Flu Crew, led by the excellent @jepekar. We traced both B3.13 in Texas and D1.1 in Nevada and Arizona to look at...

By Angela Rasmussen
Anthropic Pays $400M for AI Biotech, Touts 38,500% IRR
SocialApr 3, 2026

Anthropic Pays $400M for AI Biotech, Touts 38,500% IRR

Anthropic acquired an AI for biological research startup for just over $400 million. You can read the letter Dimension wrote to their LPs which boasts a 38,513% IRR https://t.co/wneesuT5u7

By Eric Newcomer
Nanosecond Electric Pulses Rejuvenate Aging Endothelial Cells
SocialApr 2, 2026

Nanosecond Electric Pulses Rejuvenate Aging Endothelial Cells

Nanosecond pulsed electric field applications rejuvenate aging endothelial cells by rescuing mitochondrial-to-nuclear retrograde communication https://t.co/DT8GXNLlxO

By Michael Lustgarten, PhD
FDA's Future: New CBER Chief & Rare Disease Flexibility
SocialApr 2, 2026

FDA's Future: New CBER Chief & Rare Disease Flexibility

On this week’s pod, we chatted with @docrodwong about the FDA, the next CBER chief and regulatory flexibility for rare diseases https://t.co/f6L7gwcNsr via @statnews

By Adam Feuerstein
Ancient Ig-Like Domain Controls Disease-Linked SWI/SNF Complexes
SocialApr 2, 2026

Ancient Ig-Like Domain Controls Disease-Linked SWI/SNF Complexes

a (presumably primordial) Ig-like domain regulates the disease relevant SWI/SNF chromatin remodeling complexes that's pretty cool https://t.co/Iit0Swrx0I

By Paul D. Rennert
Blocking KDM4 Reactivates Tumor Suppressor, Halts AML
SocialApr 2, 2026

Blocking KDM4 Reactivates Tumor Suppressor, Halts AML

Scientists have restored a silenced tumor-suppressor gene in mice with acute myeloid leukemia by blocking KDM4 enzymes, suggesting a potential new therapeutic approach that avoids harming normal blood cells. leukemia

By Phys.org Threads
Seeking Alternative Tools for Genetic Code Sequence Search
SocialApr 2, 2026

Seeking Alternative Tools for Genetic Code Sequence Search

Anyone know of software or a web server that can search a sequence for alternative genetic codes? Been trying to install Codetta https://t.co/Wd7IMD23Cy but can't get it running so looking for alternatives.

By Jonathan Eisen
Lowering Barriers Unlocks Biotech’s Biggest Potential
SocialApr 2, 2026

Lowering Barriers Unlocks Biotech’s Biggest Potential

What if the biggest unlock in biotech is simply access? Douglas Crawford built MBC BioLabs to lower barriers and enable 500+ startups. Excited to have him at SynBioBeta 2026. Visit the @SynBioBeta website to read the full article. https://t.co/HEfhvmwZ8i

By John Cumbers
Collaboration Between Bioinformaticians and Wet Biologists Drives Science
SocialApr 2, 2026

Collaboration Between Bioinformaticians and Wet Biologists Drives Science

🧵The most underrated superpower in science: Bioinformaticians and wet biologists working together. Here’s why it matters. https://t.co/PRuGiq6CbV

By Ming Tang
BeamTx's Risto‑cel Shows Promising Phase
SocialApr 2, 2026

BeamTx's Risto‑cel Shows Promising Phase

1/@BeamTx announced the publication of clinical data from its Phase 1/2 BEACON clinical trial evaluating risto-cel - formerly known as $BEAM-101 for the treatment of sickle cell disease (SCD). The data was presented at #ASH25 🧵👇 & was published in...

By Yair Einhorn
Patients Maintain Weight Loss After Discontinuing GLP‑1s, Epic Shows
SocialApr 2, 2026

Patients Maintain Weight Loss After Discontinuing GLP‑1s, Epic Shows

Interesting data from Epic medical records - suggests that for many patients in the "real world", they are able to keep the weight off after stopping GLP1s... https://t.co/dHfYdG6rEX #EpicResearch

By Bruce Booth
Creatine Plus Probiotic Eases Depression via Gut‑brain Energy Boost
SocialApr 2, 2026

Creatine Plus Probiotic Eases Depression via Gut‑brain Energy Boost

1/2) New placebo-controlled human randomized controlled trial finds creatine + a specific probiotic is effective in treating depression. The mechanism is fascinating, involving the probiotic increasing creatine transporters in the gut, leading to increased brain energy metabolism. If you're passionate about this...

By Nick Norwitz MD PhD
Sinclair Reverses Mouse Infertility, Challenges Menopause Limits
SocialApr 2, 2026

Sinclair Reverses Mouse Infertility, Challenges Menopause Limits

David Sinclair's lab just reversed infertility in mice that had been infertile for 6 months. They took 16-month-old mice, the equivalent of a woman well past menopause, and made them produce offspring again. The belief has always been that mammals run out...

By John Cumbers
Young Plasma Boosts Antioxidant Defense, Preserves Aged Lungs
SocialApr 2, 2026

Young Plasma Boosts Antioxidant Defense, Preserves Aged Lungs

Young plasma transfer enhances antioxidant defense and preserves structural integrity in aged lung tissue https://t.co/v1lR1EyCKv https://t.co/ZYJu1qNsDl

By David Barzilai, MD PhD
Biotech Gains as Pharma Approval Success Diverges
SocialApr 2, 2026

Biotech Gains as Pharma Approval Success Diverges

Pharma has varying levels of success developing drugs. That's a boon for biotech Here are the biopharma companies ranked by likelihood of first approval (LoA%) from 2006-2022 $AMGN, $NVO, #Eisai top the list $GSK, #Astellas, $ABBV are at the bottom #learnbiotechinvesting #BiotechPrometheus

By Biotech Investor
Clinicians Invited to Join Controlled MDMA Study at UCL
SocialApr 2, 2026

Clinicians Invited to Join Controlled MDMA Study at UCL

Clinicians: UCL and Drug Science invite you to contribute to a controlled exploration of MDMA’s psychological effects. Eligible participants will undergo two medically supervised sessions at UCL. This work aims to build a psychoanalytically grounded model of its therapeutic action....

By David Nutt
China’s Clinical Trials Surge, Outpacing US and Europe
SocialApr 2, 2026

China’s Clinical Trials Surge, Outpacing US and Europe

In 2010, China accounted for fewer than 8% of global clinical trials. By 2020, it had surpassed both US & Europe in registered trials. By 2024, China was initiating more than 5,000 clinical trials a year — a more than...

By Linda Yueh
Injectable Satellite Livers May Replace Transplants
SocialApr 2, 2026

Injectable Satellite Livers May Replace Transplants

Injectable “satellite livers” could offer an alternative to liver transplantation by Anne Trafton @MIT Learn more: https://t.co/HZg5qoXutb #HealthTech #ArtificialIntelligence #MachineLearning https://t.co/V4W3VUpDbw

By Ron van Loon
New FDA‑approved Oral Weight‑loss Pill Expands Patient Options
SocialApr 2, 2026

New FDA‑approved Oral Weight‑loss Pill Expands Patient Options

So… hot off the press: a NEW weight loss PILL just got FDA approved. We’ve had oral (non-injectable) GLP-1s before — but this is one of the first specifically for weight management. When it reaches Malaysia, it could significantly increase demand...

By Marissa Dinar, MD
Nasal Dantrolene Nanoparticles Curb Inflammation‑induced Depression, Anxiety
SocialApr 2, 2026

Nasal Dantrolene Nanoparticles Curb Inflammation‑induced Depression, Anxiety

Intranasal dantrolene nanoparticles inhibit lipopolysaccharide-induced depression and anxiety behavior in mice [Context: Dantrolene is a skeletal muscle relaxant used for malignant hyperthermia and chronic spasticity from spinal cord injuries, MS, or stroke. It inhibitings calcium release in muscle cells. Common side...

By David Barzilai, MD PhD
Vibecoding Streamlines Transcriptome to Pfam to NCBI Workflow
SocialApr 2, 2026

Vibecoding Streamlines Transcriptome to Pfam to NCBI Workflow

Amazing how far you can push vibecoding if you know what you need and the general theory behind the tool chains needed to get your result. I can now load a transcriptome dataset, find the pfam associated with that transcript,...

By Sebastian Cocioba
Bioelectric Reprogramming Repairs Birth Defects, Sparks Rejuvenation Hope
SocialApr 2, 2026

Bioelectric Reprogramming Repairs Birth Defects, Sparks Rejuvenation Hope

Fixing Birth Defects With Bioelectrical Reprogramming (Featuring Michael Levin, PhD) Aging and rejuvenation next? https://t.co/CHaRqozCph

By Michael Lustgarten, PhD
NEJM Review Overlooks Inflammation in GLP‑1 Drugs
SocialApr 1, 2026

NEJM Review Overlooks Inflammation in GLP‑1 Drugs

A new review of the GLP-1 receptor drugs @NEJM https://t.co/PK03jApZWB surprisingly, the word inflammation only appears once, in this diagram https://t.co/1PeBakBAQb

By Eric Topol
CBP and FDA Seize 5,000 Peptide Packages, Including GLP‑1 Drugs
SocialApr 1, 2026

CBP and FDA Seize 5,000 Peptide Packages, Including GLP‑1 Drugs

5000 packages of peptides seized by CBP and FDA “The seized materials included several GLP-one medications such as retatrutide, semaglutide, and tirzepatide. Officers also found various other peptides prohibited by the U.S. Food and Drug Administration, including MOTS-C, TB10, semax, and...

By Bijan Salehizedah
Vitamin B3 May Undermine Pancreatic Cancer Chemotherapy
SocialApr 1, 2026

Vitamin B3 May Undermine Pancreatic Cancer Chemotherapy

Title and header via the @cwru press release: New research reveals dangers of ‘anti-aging’ supplements in cancer protection Vitamin B3 could be making chemotherapy less effective in pancreatic cancer patients https://t.co/vIfcvuiS6P Discussion + thoughtful debate welcome👇👨‍⚕️ https://t.co/aHewoWeIle

By David Barzilai, MD PhD
AI-Driven Biology Could Slash Drug Trial Failures Dramatically
SocialApr 1, 2026

AI-Driven Biology Could Slash Drug Trial Failures Dramatically

AI for biology will have bigger near term wins. The ability for AI to learn from experiments and predict human biology will have very broad impacts in predicting targets, clinical trials, and precision medicine. Tackling the biggest challenge in Pharma (80%...

By Vijay Pande
Genome Editing Shows Promise for Sickle Cell, Β‑Thalassemia
SocialApr 1, 2026

Genome Editing Shows Promise for Sickle Cell, Β‑Thalassemia

3 new trial results for genome editing of sickle cell disease and β-thalassemia @NEJM https://t.co/qGGdjgKqP5 (with summary Table below) https://t.co/RdiM3urCKJ https://t.co/W15cPAfMoS https://t.co/F3PHKuktPx https://t.co/t6Z35S8L7h

By Eric Topol
New Early-Stage Cancer Drugs Emerge at AACR26
SocialApr 1, 2026

New Early-Stage Cancer Drugs Emerge at AACR26

A look at some promising early stage drug developments coming down the pike at #AACR26. A few of these concepts were not on the radar a couple of years ago: https://t.co/w6oD4CEckq https://t.co/kfR1AXG41K

By Sally Church
NAD+ Decline Drives Cardiac Aging; NR Restores Rhythm
SocialApr 1, 2026

NAD+ Decline Drives Cardiac Aging; NR Restores Rhythm

NAD+ controls circadian rhythmicity during cardiac aging https://t.co/NNVx94IIC8 Fig. 2: Cardiac NAD+ decreases with aging, with restoration by supplementation with nicotinamide riboside. https://t.co/z4uSqKrYjR

By David Barzilai, MD PhD
IVNS1ABP Mutation Triggers Premature Aging and Neurodegeneration
SocialApr 1, 2026

IVNS1ABP Mutation Triggers Premature Aging and Neurodegeneration

A mutation in the IVNS1ABP gene causes a new disease combining premature aging and severe neurological decline by disrupting cell scaffolding, leading to DNA damage and “zombie-like” senescent cells. https://t.co/xtDrjy72h4

By Liz Parrish